Poster: Modelling the tumor shrinkage pharmacodynamics with BlenX

2011 IEEE 1st International Conference on Computational Advances in Bio and Medical Sciences, ICCABS 2011

Volumn , Issue , 2011, Pages 251-

  Lecca, P ^a   Kahramanogullari, O ^a   Morpurgo, D ^a   Priami, C ^a   Soo, Ross A ^b  

^a UNIVERSITY OF TRENTO   (Italy)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

BlenX; Pharmacodynamics; Tumor shrinkage

Indexed keywords

BLENX; CARBOPLATIN; GEMCITABINE; HUMAN PATIENTS; LUNG TUMOR; TIME COURSE;

CHEMOTHERAPY; PHARMACODYNAMICS; SHRINKAGE; TUMORS;

MEDICAL COMPUTING;

EID: 79953835613     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/ICCABS.2011.5729904     Document Type: Conference Paper

References (4)

1. L. Dematté, C. Priami, and A. Romanel, "The BetaWorkbench: a computational tool to study the dynamics of biological systems," Briefings in Bioinformatics, vol. 9, no. 5, pp. 437-448, 2008.
2. P. Lecca, A. Palmisano, A. E. C. Ihekwaba, and C. Priami, "Calibration of dynamic models of biological systems with kinfer," European Journal of Biophysics, vol. 39, no. 6, p. 1019, 2010.
3. L.-S. Tham, L. Wang, R. A. Soo, S.-C. Lee, H.-S. Lee, Wei-PengYong, B.-C. Goh, and N. H. Holford, "A pharmacodynamic model for the time course of tumor shrinkage by gemcitabine + carboplatin in non-small cell lung cancer patients," Cancer Therapy: Clinical, vol. 14, no. 13, pp. 4213-4218, 2008.
4. V. Heinemann, Y.-Z. Xu, S. Chubb, A. Sen, L. W. H. nd G. B. Grindey, and W. Plunkett, "Cellular elimination of 2', 2'-difluorodeoxycytidine 5'-triphosphate: A mechanism of self-potentiation," Cancer Research, vol. 52, pp. 533-539, 1999.